RT Journal Article
SR Electronic
T1 Proton relaxation enhancement associated with iodinated contrast agents in MR imaging of the CNS.
JF American Journal of Neuroradiology
JO Am. J. Neuroradiol.
FD American Society of Neuroradiology
SP 19
OP 27
VO 13
IS 1
A1 J R Jinkins
A1 J W Robinson
A1 L Sisk
A1 G D Fullerton
A1 R F Williams
YR 1992
UL http://www.ajnr.org/content/13/1/19.abstract
AB PURPOSE To study the effects of iodinated radiographic contrast agents on proton relaxation in MR imaging.PATIENTS AND METHODS Two patients were evaluated after the intrathecal administration of an iodinated nonionic contrast agent (Isovue) and five subjects with cranial tumors following the intravenous administration of an iodinated ionic contrast medium (Renografin).RESULTS Both patients with subarachnoid iodinated contrast media demonstrated a relative reduction in T1 and/or T2 times using a spin-echo sequence, while four of five of the subjects with intracranial tumors (one glioma, one dural metastasis, three meningiomas) and intravenous enhancement revealed a visible MR effect. Confirmation of these in vivo observations was obtained by in vitro measurement of T1 and T2 while varying the concentration of the contrast media in saline. All iodinated contrast media showed progressively reduced relaxation times (T1 and T2) as the concentration of the agent was increased. The largest contributing relaxation mechanism is probably due to the binding and exchange of the surrounding water with the contrast molecules.CONCLUSION The observed T1/T2 effects suggest that administration of iodinated contrast media in the period immediately prior to MR scanning may be contraindicated in selected cases due to the demonstrated alteration of MR signal intensity that may lead to diagnostic inaccuracies.